SCHEDULE 13D/A: Gilde Healthcare Reduces Stake in CVRx, Inc. Below Five Percent Threshold
Schedule 13D Amendment
Gilde Healthcare entities have filed an Amendment No. 3 to their Schedule 13D, disclosing that their beneficial ownership in CVRx, Inc. has fallen below the 5% reporting threshold as of February 4, 2025.
Summary
- Cooperatieve Gilde Healthcare IV U.A., along with its related entities Gilde Healthcare IV Management B.V., Gilde Healthcare Holding B.V., Manapouri B.V., and Martemanshurk B.V. (collectively, 'Gilde Healthcare'), filed Amendment No. 3 to their Schedule 13D.
- The filing indicates that as of February 4, 2025, Gilde Healthcare ceased to be the beneficial owner of more than five percent of the Common Stock of CVRx, Inc.
- As of December 31, 2024, CVRx, Inc. had 25,324,684 shares of Common Stock outstanding.
- Gilde Healthcare's aggregate beneficial ownership is now 1,231,490 shares of Common Stock, which includes 1,229,022 shares held directly and 2,468 options exercisable within 60 days of February 4, 2025.
- This beneficial ownership represents approximately 4.9% of the outstanding Common Stock of CVRx, Inc.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory disclosure of a change in beneficial ownership. While a reduction in a significant investor's stake could be interpreted negatively, the filing itself provides no context or rationale for the change, making its direct sentiment impact neutral.
Future Outlook
NA
Industry Context
This filing is a standard regulatory disclosure regarding a change in a significant investor's stake in a publicly traded company. It does not provide information on broader industry trends or competitive landscape, but rather reflects a specific investment decision by Gilde Healthcare concerning CVRx, Inc.
Stakeholder Impact
- Shareholders: The reduction of Gilde Healthcare's stake below 5% means a significant institutional investor now holds a smaller, non-reportable position, which could be interpreted by other investors as a change in institutional confidence or investment strategy regarding CVRx, Inc.
Key Dates
| Date | Description |
|---|---|
| 2021-07-12 | Original Schedule 13D filing date. |
| 2023-12-29 | Amendment No. 1 to Schedule 13D filed. |
| 2024-01-19 | Amendment No. 2 to Schedule 13D filed. |
| 2024-12-31 | Date for which CVRx, Inc.'s outstanding shares were reported (25,324,684 shares). |
| 2025-02-04 | Date of event which required the filing, when Reporting Persons ceased to be beneficial owners of more than five percent of Common Stock. |
| 2025-02-06 | Date of filing of Amendment No. 3 to Schedule 13D. |
Keywords
CVRx Inc, Gilde Healthcare, Schedule 13D, Beneficial Ownership, Common Stock, SEC Filing, Shareholder Update, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.